ClinicalTrials.gg
CompletedNCT06821841Updated Mar 23, 2026

Online Physical Activity Intervention for Peri- and Post-menopausal Working Women

An interventional study of Online Physical Activity Group and Information Leaflet in Perimenopausal Women and Postmenopausal, sponsored by Canterbury Christ Church University. Completed at 1 site in United Kingdom. Open to female participants aged 30 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by Canterbury Christ Church University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
30 Years to 60 Years
Sex
Female
01

Study summary

It is the purpose of this clinical trial to examine the feasibility and acceptability of a brief online physical activity group (incorporating motivational interviewing) for UK women who are currently experiencing peri- or post-menopausal symptoms and working full-time. To measure feasibility and acceptability, the following will be examined: 1. The ease that participants were recruited; 2. The proportion of participants that remained in the online physical activity group (attending at least half of the sessions); 3. The proportion of participants that remained in the study; 4. How acceptable the participants find the online physical activity group; 5. Whether there is a preliminary indications that the online physical activity group may increase participant activity levels. Once provided informed consent, all participants will be randomly allocated into either the online physical activity group (intervention arm) or the control group. Participants will be asked to complete outcome measures at the same four timepoints, as well as completing a weekly physical activity log.

Read the detailed description

This pilot RCT seeks to examine the feasibility and acceptability of an online physical activity group (incorporating motivational interviewing) for UK women experiencing peri- or post-menopausal symptoms and currently working full-time. Having provided informed consent, all participants will be randomly allocated to either the online physical activity group (intervention arm) or control group. Those in the online physical activity group will be invited to attend 4-weekly sessions that last 45-60 minutes, as well as receiving and information leaflet based on Chief Medical Officer (CMO) guidelines. The control group will receive the same information leaflet based on CMO guidelines only and will be able to use this as they wish. Self-report questionnaires will be administered online at the same four timepoints; 1. Baseline (week 0-1) - all participants will complete demographic information, IPAQ, MRS and WPAI; 2. 1-week (week 1) - all participants will complete the IPAQ only; 3. Post-intervention (week 8-9) - all participants will complete the IPAQ, MRS and WPAI. Participants in the intervention arm will complete an additional feedback questionnaire; 4. 1-month follow-up (week 12-13) - all participants will complete the IPAQ, MRS and WPAI. Feasibility and acceptability will be examined by: 1. The ease that participants were recruited; 2. The proportion of participants that remained in the online physical activity group (attending at least half of the sessions); 3. The proportion of participants that remained in the study; 4. How acceptable the participants find the online physical activity group; 5. Whether there is a preliminary indications that the online physical activity group may increase participant activity levels. These outcomes will be examined against pre-defined progression criteria (based on previous literature and outlined in the outcome measures section), to determine whether the intervention is feasible and acceptable to progress to a full-scale RCT at a later date.

02

Conditions studied

  • Perimenopausal Women
  • Postmenopausal

Keywords

  • online physical activity group
03

In context

Lead sponsor

Canterbury Christ Church University is the lead sponsor of 27 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female
  • Aged 30-60 years
  • Currently working full-time (approximately 35+ hours per week)
  • Currently experiencing perimenopausal (women with newly inconsistent menstrual cycles, >1 year since last cycle) or (cessation of menstrual cycle for >12 months) symptoms, which are impacting functioning
  • Currently physically inactive or not meeting recommended government guidelines (150-minutes of moderate-vigorous physical activity per week)
  • No comorbid health conditions that impact ability to participate in physical activity

Exclusion criteria

Exclusion Criteria:

- Those who do not meet the inclusion criteria.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Online Physical Activity Group

    Behavioral: Online Physical Activity Group · Behavioral: Information Leaflet

  • Other
    Control - Information Leaflet Only

    Behavioral: Information Leaflet

Interventions

  • BehavioralOnline Physical Activity Group

    The online physical activity group will consist of four 45-60-minute sessions, which participants allocated to this group will be asked to commit to. These sessions will be delivered online and occur for 4 weeks. Discussions within the sessions will incorporate motivational interviewing, focussing on the benefits of physical activity, current physical activity levels, barriers to physical activity and overcoming these, motivation to complete physical activity, and goal setting. Participants allocated to this group will receive weekly reminders to promote attendance. Participants will also be asked to complete a weekly physical activity log that includes detail about the type of physical activity they completed, the duration, intensity, context and comments.

  • BehavioralInformation Leaflet

    Participants will receive an information leaflet that includes information about menopause (e.g. definition, symptoms), the benefits of physical activity for menopause, recommended weekly physical activity levels (based on CMO guidelines), examples of physical activity, and signposting to online resources. Participants will be able to use the information leaflet as they wish, and complete a weekly physical activity log that includes detail about the type of physical activity completed, the duration, intensity, context and comments.

06

What researchers measure

Primary outcomes

  1. Number of participants recruited to the study

    The number of participants recruited will be compared to pre-defined progression criteria, based on existing literature, to examine the feasibility of recruitment. This progression criteria will follow a traffic light system; Green = 40-50 participants, Amber = \>24 participants, Red = \<24 participants.

    Time frame: 9 months from the start of recruitment

  2. Retention rate of participants attending the online intervention

    The proportion of participants who attend at least half of the online physical activity group sessions, which will be compared to progression criteria; Green = \>50%, Amber = 25-49%, Red = \<25%.

    Time frame: Week 0 to 8-9

  3. The retention rate of participants who remain in the study as a whole

    The proportion of participants who remain in the study, compared to progression criteria: Green = \>50%, Amber = 25-49%, Red = \<25%

    Time frame: Week 0 to 12-13

  4. Acceptability of the online physical activity group intervention

    Participant responses to the feedback questionnaire, including Likert-scale questions and content analysis of qualitative questions. This will be compared to progression criteria; Green = High satisfaction/acceptability from the majority of participants, with a mean of 7/10 on the Likert-scale questions, Amber = Moderate/Inconsistent satisfaction and acceptability indicated, Red = Low satisfaction/acceptability from the majority of participants

    Time frame: Week 8-9

  5. Preliminary indicator of effectiveness for the primary outcome (physical activity)

    Estimate of the between group effect size for the online physical activity group compared to control group on the International Physical Activity Questionnaire-Short Form (IPAQ-SF), from baseline \[Week 0 - 1\] to post-intervention and follow-up \[Week 8-9 and Week 12-13, respectively\]. This will be compared to progression criteria; Green = the between-group effect size is in favour of the intervention, with a substantial number of participants (\>50%) showing reliable change (according to the calculated Reliable Change index; Jacobson \& Truax, 1991), Amber = between-group effect size is in favour of the intervention arm, with a small number of participants showing reliable change (25-49%), Red = between-group effect size is in favour of the control group, with a minimal number of participants in the intervention group showing reliable change (\<25%). For the IPAQ, greater scores indicate higher physical activity levels (better outcome).

    Time frame: Week 8-9 and 12-13

Secondary outcomes

  1. Estimate of between group effect size for change on the International Physical Activity Questionnaire-Short Form (IPAQ-SF) from baseline to post-intervention and 1-month follow-up

    Estimate of the between group effect size of the online physical activity group compared to control group on change on the International Physical Activity Questionnaire - Short Form (IPAQ-SF) from baseline (week 0-1) to post intervention (week 8-9) and follow-up (week 12-13). The IPAQ-SF is a 7-item questionnaire that assesses an individual's physical activity levels (e.g. walking, moderate-intensity, vigorous-intensity) and sedentary behaviour (e.g. sitting). Higher scores on the IPAQ-SF indicates more physical activity.

    Time frame: Week 8-9 and 12-13

  2. Estimate of between group effect size for the Menopause Rating Scale (MRS) from baseline to post-intervention and 1-month follow-up

    Estimate of the between group effect size of the online physical activity group compared to control group on change on the Menopause Rating Scale (MRS) from baseline (week 0-1) to post-intervention (week 8-9) and follow-up (week 12-13). The MRS is an 11-item questionnaire that assesses the severity of various menopausal symptoms (somatic, psychological and urogenital) using a 5-point Likert-scale. Higher scores on the MRS indicate greater symptoms severity.

    Time frame: Week 8-9 and 12-13

  3. Estimate of between group effect size for the Work Productivity and Activity Impairment Questionnaire (WPAI) from baseline to post-intervention and 1-month follow-up

    Estimate of the between group effect size of the online physical activity group compared to control group on the change on the Work Productivity and Activity Impairment Questionnaire (WPAI) from baseline (week 0-1) to post-intervention (week 8-9) and follow-up (week 12-13). The WPAI is a self-report questionnaire that measures the impact of a specific health difficulty on work (e.g. absenteeism, work productivity) and daily activities (e.g. household chores, hobbies). Higher scores on the WPAI indicate greater impact on work.

    Time frame: Week 8-9 and 12-13

Other outcomes

  1. Test-Retest Reliability of the International Physical Activity Questionnaire-Short Form (IPAQ-SF)

    Before the intervention begins, the IPAQ-SF will be completed at baseline (week 0-1) and 1-week later. This will enable a reliability coefficient for the IPAQ-SF to be calculated for this population, which will later be used to calculate the Reliable Change Index (RCI) for participants.

    Time frame: Week 0-1 (baseline) to week 1-2

07

Study locations

1 site
  • Salomons Institute for Applied Psychology, Canterbury Christ Church University
    Royal Tunbridge Wells, Kent TN1 2YG, United Kingdom
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2025 to primary completion in Dec 2025, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 11, 2025
First posted
Feb 12, 2025
StartActual
May 29, 2025
Primary completionActual
Dec 22, 2025
CompletionActual
Dec 22, 2025
Last update
Mar 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06821841
Lead sponsor
Canterbury Christ Church University
Responsible party
Sponsor
First posted
Feb 12, 2025
Start date
May 29, 2025
Primary completion
Dec 22, 2025
Completion
Dec 22, 2025
Last update
Mar 23, 2026

Study contacts

Dr Fergal Jones
study chair · Canterbury Christ Church University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion